Senju DRC A Double-Masked, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of MT-0814 for the Treatment of Patients with Age-Related Macular Degeneration
Research Grant
Administered By
Ophthalmology
Awarded By
Senju Pharmaceutical Co, Ltd.
Start Date
April 11, 2019
End Date
May 26, 2021
Administered By
Ophthalmology
Awarded By
Senju Pharmaceutical Co, Ltd.
Start Date
April 11, 2019
End Date
May 26, 2021